The Allogeneic Effect Revisited: Exogenous Help for Endogenous, Tumor-Specific T Cells

Heather J. Symons, Moshe Y. Levy, Jie Wang, Xiaotao Zhou, Gang Zhou, Sarah E. Cohen, Leo Luznik, Hyam I. Levitsky, Ephraim J. Fuchs

Research output: Contribution to journalArticlepeer-review

29 Scopus citations


The "allogeneic effect" refers to the induction of host B cell antibody synthesis or host T cell cytotoxicity, including tumoricidal activity, by an infusion of allogeneic lymphocytes. We show that treatment of mice with cyclophosphamide (Cy) followed by CD8+ T cell-depleted allogeneic donor lymphocyte infusion (Cy + CD8- DLI) induces regression of established tumors with minimal toxicity in models of both hematologic and solid cancers, even though the donor cells are eventually rejected by the host immune system. The optimal antitumor effect of Cy + CD8- DLI required the presence of donor CD4+ T cells, host CD8+ T cells, and alloantigen expression by normal host but not tumor tissue. The results support a model in which a donor CD4+ T cell-mediated graft-versus-host (GVH) reaction effectively awakens antitumor immunity among Cy-resistant host CD8+ T cells. These events provide the cellular mechanism of the "allogeneic effect" in antitumor immunity. Cy + CD8- DLI may be an effective and minimally toxic strategy for awakening the host immune response to advanced cancers.

Original languageEnglish (US)
Pages (from-to)499-509
Number of pages11
JournalBiology of Blood and Marrow Transplantation
Issue number5
StatePublished - May 2008
Externally publishedYes


  • Adoptive immunotherapy
  • Allogeneic
  • Cyclophosphamide
  • Graft-versus-host disease
  • Lymphocyte subsets
  • graft-versus-tumor effects

ASJC Scopus subject areas

  • Hematology
  • Transplantation


Dive into the research topics of 'The Allogeneic Effect Revisited: Exogenous Help for Endogenous, Tumor-Specific T Cells'. Together they form a unique fingerprint.

Cite this